Published in Cost Eff Resour Alloc on June 17, 2010
Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis. Neurol Sci (2014) 0.89
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe. Front Immunol (2014) 0.88
Manufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacy. Front Immunol (2014) 0.78
Advances in the treatment of chronic inflammatory demyelinating neuropathies in 2010. J Neurol (2011) 0.76
Neuromuscular disease: IVIg for neuromuscular disease-effective but expensive. Nat Rev Neurol (2012) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol (2008) 3.59
High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology (1990) 3.05
Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med (1994) 2.89
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (2001) 2.00
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2001) 1.88
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance. Neurology (1990) 1.67
Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc (2001) 1.42
Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry (1993) 1.28
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry (1999) 1.27
Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev (2005) 1.20
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain (1996) 1.16
Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev (2007) 1.14
Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol (1999) 1.08
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2003) 1.04
A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol (1996) 1.03
Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Curr Med Res Opin (2006) 0.92
Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol (1994) 0.91
Chronic inflammatory demyelinating polyneuropathy. Neurol Clin (2007) 0.89
Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis. Rheumatology (Oxford) (2003) 0.87
A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy. Transfus Apher Sci (2005) 0.81
Cost-effectiveness of reducing wait times for cataract surgery in Ontario. Can J Ophthalmol (2008) 0.78
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
The impact of conservation on the status of the world's vertebrates. Science (2010) 6.71
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med (2008) 4.03
Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA (2006) 3.83
Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ (2011) 3.81
Cast versus splint in children with minimally angulated fractures of the distal radius: a randomized controlled trial. CMAJ (2010) 3.15
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making (2002) 2.53
Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med (2007) 2.50
Disruption of tumor neovasculature by microbubble enhanced ultrasound: a potential new physical therapy of anti-angiogenesis. Ultrasound Med Biol (2011) 2.18
Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology (2009) 2.05
'What would my classmates say?' An international study of the prediction-based method of course evaluation. Med Educ (2013) 2.03
Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med (2011) 1.97
A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ (2003) 1.93
The essential neurologic examination: what should medical students be taught? Neurology (2009) 1.83
Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain (2008) 1.76
Script concordance testing: a review of published validity evidence. Med Educ (2011) 1.73
Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol (2005) 1.68
Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making (2011) 1.67
Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol (2003) 1.66
Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation (2005) 1.62
Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review. Expert Rev Pharmacoecon Outcomes Res (2014) 1.58
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
Sex differences in hospital admissions from emergency departments in asthmatic adults: a population-based study. Ann Allergy Asthma Immunol (2006) 1.57
Is there a higher risk of restless legs syndrome in peripheral neuropathy? Neurology (2008) 1.55
A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med (2005) 1.54
Coverage with evidence development: the Ontario experience. Int J Technol Assess Health Care (2011) 1.53
Which pedagogical principles should clinical teachers know? Teachers and education experts disagree. Disagreement on important pedagogical principles. Med Teach (2009) 1.52
The Script Concordance Test: a new tool assessing clinical judgement in neurology. Can J Neurol Sci (2009) 1.51
Value of dobutamine stress myocardial contrast perfusion echocardiography in patients with advanced liver disease. Liver Transpl (2006) 1.51
Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J Clin Microbiol (2009) 1.51
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy. Can J Cardiol (2002) 1.49
Surgical treatment of facial soft-tissue deformities in postburn patients: a proposed classification based on a retrospective study. Plast Reconstr Surg (2013) 1.46
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Can J Cardiol (2004) 1.46
Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J (2012) 1.44
Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly. Eur Heart J (2007) 1.44
The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. J Bone Joint Surg Am (2007) 1.42
Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol (2010) 1.41
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes (2008) 1.40
The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc (2011) 1.38
Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing. Heart Rhythm (2005) 1.38
A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up. Surg Innov (2006) 1.37
Assessing the quality of reports of randomized trials in pediatric complementary and alternative medicine. BMC Pediatr (2002) 1.36
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health (2010) 1.32
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol (2005) 1.25
Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin (2007) 1.23
A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci Transl Med (2013) 1.22
Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol (2004) 1.22
Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates. Can Fam Physician (2013) 1.21
Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.21
The economics of health information technology in medication management: a systematic review of economic evaluations. J Am Med Inform Assoc (2011) 1.20
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2004) 1.20
A review of the cost of cardiovascular disease. Can J Cardiol (2009) 1.20
Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke (2004) 1.17
Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: the Ontario experience. Int J Technol Assess Health Care (2007) 1.16
A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc (2011) 1.15
Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients. Circulation (2013) 1.15
Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol (2009) 1.14
Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes (2010) 1.09
Microbubble cavitation imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 1.08
Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Qual Life Res (2008) 1.08
Common Drug Review recommendations: an evidence base for expectations? Pharmacoeconomics (2012) 1.08
Patient views on reminder letters for influenza vaccinations in an older primary care patient population: a mixed methods study. Can J Public Health (2008) 1.06
Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: Adjusting for the burden of ensuing chronic kidney disease. Can Urol Assoc J (2013) 1.05
Evidence against the involvement of chronic cerebrospinal venous abnormalities in multiple sclerosis. A case-control study. PLoS One (2013) 1.04
Cardiovascular Health Awareness Program (CHAP): a community cluster-randomised trial among elderly Canadians. Prev Med (2008) 1.04
The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque. Cardiovasc Res (2006) 1.03
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. Can J Cardiol (2002) 1.02
Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data. Am Heart J (2006) 1.00
Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43. J Nat Prod (2013) 1.00
Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol (2009) 1.00
Can virtual reality improve anatomy education? A randomised controlled study of a computer-generated three-dimensional anatomical ear model. Med Educ (2006) 1.00
The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord (2011) 0.99
Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada. Value Health (2003) 0.99
Tissue expansion in the treatment of giant congenital melanocytic nevi of the upper extremity. Medicine (Baltimore) (2017) 0.97
Effects of study design and trends for EVAR versus OSR. Vasc Health Risk Manag (2008) 0.97
Differences in definity and optison microbubble destruction rates at a similar mechanical index with different real-time perfusion systems. J Am Soc Echocardiogr (2003) 0.97
The use of microbubbles to target drug delivery. Cardiovasc Ultrasound (2004) 0.97